GUIFFRE CHRISTOPHERD T. - 03 Dec 2021 Form 4 Insider Report for Pear Therapeutics, Inc.

Role
CFO, COO, Treas., & Asst. Sec.
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Dec 2021
Net transactions value
$0
Form type
4
Filing time
07 Dec 2021, 16:24:03 UTC
Next filing
18 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEARQ Stock Option (Right to Buy) Award +478,533 478,533 03 Dec 2021 Common Stock 478,533 $0.6800 Direct F1, F2
transaction PEARQ Stock Option (Right to Buy) Award +51,533 51,533 03 Dec 2021 Common Stock 51,533 $0.7200 Direct F3, F4
transaction PEARQ Stock Option (Right to Buy) Award +103,068 103,068 03 Dec 2021 Common Stock 103,068 $1.08 Direct F5, F6
transaction PEARQ Stock Option (Right to Buy) Award +242,948 242,948 03 Dec 2021 Common Stock 242,948 $1.09 Direct F7, F8
transaction PEARQ Stock Option (Right to Buy) Award +228,224 228,224 03 Dec 2021 Common Stock 228,224 $1.29 Direct F9, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vested or shall vest on December 7, 2018 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each one month period thereafter.
F2 Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for an option to acquire 325,000 shares of common stock of Private Pear for $1.00 per share.
F3 25% of the shares underlying the option vested or shall vest on December 7, 2018 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each one month period thereafter.
F4 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 35,000 shares of common stock of Private Pear for $1.05 per share.
F5 25% of the shares underlying the option vested or shall vest on March 14, 2020 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F6 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 70,000 shares of common stock of Private Pear for $1.58 per share.
F7 25% of the shares underlying the option vested or shall vest on March 24, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F8 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 165,000 shares of common stock of Private Pear for $1.60 per share.
F9 25% of the shares underlying the option vested or shall vest on January 26, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F10 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 155,000 shares of common stock of Private Pear for $1.89 per share.